Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages
mBio · 08.04.2026 · 17 (4)
DOI: 10.1128/mbio.02846-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 08.04.2026. Verfasst von Marisol Perez-Toledo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom. Hauptthemen laut MEDLINE: Macrophages, Antibodies, Bacterial, Salmonella typhimurium, Salmonella Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Antibodies against Salmonella Typhimurium (STm) can provide protection against infection. Understanding how antibodies, complement, and leukocytes interact is essential and can help advance vaccine development. To evaluate the in vivo role of STm-specific antibodies, mice were immunized with an outer membrane vesicle (OMV) vaccine and subsequently challenged with STm. Immunohistology and intravital microscopy revealed that OMV-induced antibodies promoted STm uptake by macrophages in the spleen and liver, whereas bacteria were only infrequently associated with neutrophils. Depletion of monocytic cells using clodronate liposomes demonstrated that these cells help prevent antigen dissemination. Immunization and challenge experiments in mice deficient in C1q, C3, C4, or C5 showed that OMV immunization conferred protection in all groups except C3-deficient mice. Mice deficient in C3 failed to develop robust germinal center and plasma cell responses following OMV immunization. Nevertheless, C3-deficient mice that received immune sera by adoptive transfer prior to infection had significantly reduced bacterial burdens compared to mice receiving non-immune control sera. In vitro studies using human sera and THP-1 cells confirmed that antibodies alone are sufficient to promote bacterial capture by macrophages. Complement—particularly C1q and C3, but not C5—further enhanced bacterial uptake. Overall, under the conditions tested, antibodies are sufficient to reduce STm burdens in vivo and facilitate bacterial uptake in vitro , with these processes supported by complement and macrophages. IMPORTANCE Bacterial infections remain a significant global challenge, further complicated by the growing issue of antimicrobial resistance (AMR). In this context, vaccination provides a cost-effective means of preventing infections and combating the emergence of AMR strains. Antibodies are key mediators of vaccine-induced protection. However, their mechanisms of action in vivo are not fully understood. In this study, we demonstrate how antibodies enhance the capture of Salmonella by macrophages. Although these cells may be dispensable for controlling bacterial numbers, they are crucial for limiting the spread of bacterial antigens. Additionally, we find that the classical complement cascade is not necessary for bacterial clearance but does facilitate bacterial capture by macrophages. Overall, our findings reveal that multiple antibody-mediated pathways operate in vivo , exhibiting some redundancy in their combined efforts to control infection, underscoring the importance of antibody functions in limiting bacterial spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
- Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Canada.
- University Medical Center Groningen, Groningen, the Netherlands.
- Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
- MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
ORCID-Profile: Marisol Perez-Toledo, Adam F Cunningham
Förderung
- Wellcome Trust
Zitieren
APA
Perez-Toledo, M., Aksu-Istil, K., Marcial-Juarez, E., Persaud, R. R., Alshayea, A., Jossi, S. E., Carestia, A., von Meijenfeld, F., Botto, M., James, L. C., Surewaard, B., Afzal, Z., Shields, A. M., Horsnell, W. G., Lopez-Macias, C., Henderson, I. R., OptiVaNTS consortium, Jenne, C. N., & Cunningham, A. F. (2026). Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages. mBio, 17(4). https://doi.org/10.1128/mbio.02846-25
Vancouver
Perez-Toledo M, Aksu-Istil K, Marcial-Juarez E, Persaud RR, Alshayea A, Jossi SE, et al. Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages. mBio. 2026;17(4). doi:10.1128/mbio.02846-25
BibTeX
@article{PerezToledo2026,
author = {Perez-Toledo, Marisol and Aksu-Istil, Kubra and Marcial-Juarez, Edith and Persaud, Ruby R and Alshayea, Areej and Jossi, Sian E and Carestia, Agostina and von Meijenfeld, Fien and Botto, Marina and James, Leo C and Surewaard, Bas and Afzal, Zaheer and Shields, Adrian M and Horsnell, William G and Lopez-Macias, Constantino and Henderson, Ian R and OptiVaNTS consortium, OptiVaNTS consortium and Jenne, Craig N and Cunningham, Adam F},
title = {Vaccine-induced antibodies can limit Salmonella infection in the absence of complement or macrophages},
journal = {mBio},
year = {2026},
volume = {17},
number = {4},
doi = {10.1128/mbio.02846-25}
}
EUVIMED